| Miriam Habiel, MD | |
|
90 Bergen St Fl 6, Newark, NJ 07103 | |
| (973) 972-2020 | |
| Not Available |
| Full Name | Miriam Habiel |
|---|---|
| Gender | Female |
| Speciality | Ophthalmology |
| Experience | 12 Years |
| Location | 90 Bergen St Fl 6, Newark, New Jersey |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1285991737 | NPI | - | NPPES |
| 09733049 | Medicaid | MS | |
| 0637688 | Medicaid | NJ | |
| 2425196 | Medicaid | LA |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207WX0009X | Ophthalmology - Glaucoma Specialist | 25MA10153200 (New Jersey) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| The University Hospital | Newark, NJ | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| University Physician Associates Of New Jersey Inc | 9830003417 | 320 |
News Archive
Scientists have now discovered a pelvis supposed to be that of a pre-human ancestor, called Rudapithecus. Found near a historic mining community called Rudabanya in Hungary, the pelvis is remarkable not only for its rarity – the pelvis being among the fossils most rarely recovered – but also for its structure which shows that the earliest human ancestors stood upright.
For over 20 years, CEDRA Corporation, a division of Worldwide Clinical Trials, has been an industry leader in providing Bioanalytical Sciences and Phase I-IIb Clinical Research Services. Operating as a division of Worldwide Clinical Trials over the past three years, today, CEDRA Corporation announces its new company name, Worldwide Clinical Trials Drug Development Solutions.
Metabolex, Inc., a biopharmaceutical company focused on the discovery and development of proprietary new medicines for the treatment of metabolic diseases, announced that it has initiated a Phase 2 clinical trial of arhalofenate (MBX-102), its product candidate for the management of hyperuricemia in patients with gout.
Olga Boukrina, PhD, research scientist in Stroke Rehabilitation Research at Kessler Foundation, has received a $10,000 grant from the Mabel H. Flory Charitable Trust.
› Verified 7 days ago
| Entity Name | University Physician Associates Of New Jersey Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1720098320 PECOS PAC ID: 9830003417 Enrollment ID: O20040318000140 |
News Archive
Scientists have now discovered a pelvis supposed to be that of a pre-human ancestor, called Rudapithecus. Found near a historic mining community called Rudabanya in Hungary, the pelvis is remarkable not only for its rarity – the pelvis being among the fossils most rarely recovered – but also for its structure which shows that the earliest human ancestors stood upright.
For over 20 years, CEDRA Corporation, a division of Worldwide Clinical Trials, has been an industry leader in providing Bioanalytical Sciences and Phase I-IIb Clinical Research Services. Operating as a division of Worldwide Clinical Trials over the past three years, today, CEDRA Corporation announces its new company name, Worldwide Clinical Trials Drug Development Solutions.
Metabolex, Inc., a biopharmaceutical company focused on the discovery and development of proprietary new medicines for the treatment of metabolic diseases, announced that it has initiated a Phase 2 clinical trial of arhalofenate (MBX-102), its product candidate for the management of hyperuricemia in patients with gout.
Olga Boukrina, PhD, research scientist in Stroke Rehabilitation Research at Kessler Foundation, has received a $10,000 grant from the Mabel H. Flory Charitable Trust.
› Verified 7 days ago
| Entity Name | Academic Eye Center Pa |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1346268661 PECOS PAC ID: 4183691991 Enrollment ID: O20040913000193 |
News Archive
Scientists have now discovered a pelvis supposed to be that of a pre-human ancestor, called Rudapithecus. Found near a historic mining community called Rudabanya in Hungary, the pelvis is remarkable not only for its rarity – the pelvis being among the fossils most rarely recovered – but also for its structure which shows that the earliest human ancestors stood upright.
For over 20 years, CEDRA Corporation, a division of Worldwide Clinical Trials, has been an industry leader in providing Bioanalytical Sciences and Phase I-IIb Clinical Research Services. Operating as a division of Worldwide Clinical Trials over the past three years, today, CEDRA Corporation announces its new company name, Worldwide Clinical Trials Drug Development Solutions.
Metabolex, Inc., a biopharmaceutical company focused on the discovery and development of proprietary new medicines for the treatment of metabolic diseases, announced that it has initiated a Phase 2 clinical trial of arhalofenate (MBX-102), its product candidate for the management of hyperuricemia in patients with gout.
Olga Boukrina, PhD, research scientist in Stroke Rehabilitation Research at Kessler Foundation, has received a $10,000 grant from the Mabel H. Flory Charitable Trust.
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Miriam Habiel, MD 30 Bergen Street, Building 12 Room 1205, Newark, NJ 07107-3000 Ph: (973) 972-0037 | Miriam Habiel, MD 90 Bergen St Fl 6, Newark, NJ 07103 Ph: (973) 972-2020 |
News Archive
Scientists have now discovered a pelvis supposed to be that of a pre-human ancestor, called Rudapithecus. Found near a historic mining community called Rudabanya in Hungary, the pelvis is remarkable not only for its rarity – the pelvis being among the fossils most rarely recovered – but also for its structure which shows that the earliest human ancestors stood upright.
For over 20 years, CEDRA Corporation, a division of Worldwide Clinical Trials, has been an industry leader in providing Bioanalytical Sciences and Phase I-IIb Clinical Research Services. Operating as a division of Worldwide Clinical Trials over the past three years, today, CEDRA Corporation announces its new company name, Worldwide Clinical Trials Drug Development Solutions.
Metabolex, Inc., a biopharmaceutical company focused on the discovery and development of proprietary new medicines for the treatment of metabolic diseases, announced that it has initiated a Phase 2 clinical trial of arhalofenate (MBX-102), its product candidate for the management of hyperuricemia in patients with gout.
Olga Boukrina, PhD, research scientist in Stroke Rehabilitation Research at Kessler Foundation, has received a $10,000 grant from the Mabel H. Flory Charitable Trust.
› Verified 7 days ago
Dr. Ronald Rescigno, M.D. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 90 Bergen Street, Doc 6100, Newark, NJ 07103 Phone: 973-972-2036 | |
Dr. Albert S Khouri, MD Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 90 Bergen St, Suite 6100, Newark, NJ 07103 Phone: 973-972-2065 Fax: 973-972-1746 | |
Dr. David Sc Chu, MD Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 90 Bergen St, Ste 6100, Newark, NJ 07103 Phone: 973-972-2064 Fax: 973-972-2068 | |
Monique S. Roy, M.D. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 90 Bergen St, Doc 6100, Newark, NJ 07103 Phone: 973-972-2065 Fax: 973-972-1244 | |
Thomas W Materna, M.D. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 20 Ferry St, Newark, NJ 07105 Phone: 973-589-0104 Fax: 973-589-5084 | |
Dr. Marco Attilio Zarbin, MD, PHD Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 90 Bergen St, Doc 6th Floor, Room 6156, Newark, NJ 07103 Phone: 973-972-2065 Fax: 973-972-2068 |